查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830868

2025年照护现场血液学诊断全球市场报告

Point Of Care Hematology Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，照护现场，市场规模从2024年的26.6亿美元增加至2025年的29亿美元，复合年增长率达9.1%。这段历史时期的成长可归因于血液疾病盛行率的上升、医疗环境的日益分散、对早期疾病检测的日益重视、新兴市场医疗支出的不断增长以及携带式诊断设备的日益普及。

预计未来几年照护现场医疗的日益普及、对即时临床决策的需求不断增长、家庭医疗诊断的使用日益增多、血液相关疾病的盛行率不断上升以及预防性医疗保健意识的不断增强。预测期内的主要趋势包括血液分析仪的先进连接能力、样品製备方法的创新、诊断工具中人工智慧的整合、单细胞分析的发展、云端基础的数据平台的普及以及实验室晶片解决方案的进步。

照护现场血液学诊断是指在患者就诊时或附近进行的医学检测，用于快速评估血液相关疾病，例如贫血、感染疾病和凝血功能障碍。这些检测能够快速且准确地提供血液学结果，以支持及时的临床决策，尤其是在紧急情况和资源有限的环境中。这种方法最大限度地减少了对密集实验室检测的依赖，并加快了诊断和治疗。

主要的即时血液学诊断类型包括全血球计数 (CBC)、血液凝固检验、血红蛋白检测和贫血诊断。 CBC 可测量各种血液成分，包括红血球、白血球、血红素、血球容积比和血小板，有助于评估整体健康状况并检测多种疾病。这些诊断产品以处方笺和非处方两种形式的耗材和系统形式提供，服务于诊断中心、医院、血库、输血中心和其他医疗机构等最终用户。

美国关税的快速上涨以及持续至2025年春季的贸易摩擦，对医疗设备产业产生了重大影响，尤其对进口诊断影像设备零件、手术用不銹钢和塑胶耗材的影响。医院和诊所抵制涨价，挤压了製造商的净利率。监管障碍加剧了这个问题，因为与关税相关的供应商变更通常需要设备重新认证，从而延缓了产品上市时间。企业正在透过双重采购关键零件、扩大国内商品化生产以及加快高性价比材料的研发来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供照护现场血液学诊断市场统计数据，包括全球市场规模、区域份额、照护现场血液学诊断市场份额的竞争对手、照护现场血液学诊断细分市场的详细照护现场、市场趋势和商业机会，以及您在照护现场血液学诊断行业取得成功所需的数据。本研究报告对即时血液学诊断行业的照护现场和未来趋势进行了详细分析，为您提供所需的全面观点。

血液疾病的日益普及预计将推动照护现场血液学诊断市场大幅成长。血液疾病是指影响红血球、白血球、血小板和血浆的病理状况。这些疾病直接影响血液健康，是导致需要定期监测的慢性疾病日益增多的主要原因。即时血液学诊断能够在患者就诊时或附近提供快速且准确的结果，有助于及时发现和管理这些疾病，加速临床决策速度并改善疾病管理。例如，2024年4月，澳洲非营利组织珀斯血液研究所报告称，确诊患有血友病的患者人数从2021年的233,577人增加到2022年的257,146人。这一趋势凸显了照护现场血液学诊断在应对血液疾病日益增长的流行方面将发挥的重要作用。

该市场的主要参与者正在开发先进的解决方案，例如基于试剂盒的人工智慧血液学分析仪，以实现快速且准确的现场血液分析。这些紧凑型设备利用一次性试剂盒和人工智慧演算法，可直接在护理点进行全血细胞计数 (CBC) 和其他分析。例如，2024 年 9 月，美国动物用药品公司 Zoetis Inc. 推出了 Vetscan OptiCell，这是一款基于试剂盒、支援人工智慧的兽用血液学分析仪。该系统可在几分钟内快速提供参考品质的 CBC 结果，同时最大限度地减少维护和手动操作时间。人工智慧影像分析和黏弹性聚焦技术可实现准确的细胞定序、血球分类和自动异常检测，从而实现可靠且高效的诊断。

2023年6月，美国宠物相关企业, Inc.）收购了赫斯卡（Heska），收购金额未揭露。此次收购扩大了玛氏的动物诊断业务，并透过利用赫斯卡的照护现场血液学和专业诊断解决方案，巩固了玛氏在先进动物医疗保健领域的地位。

照护现场血液学诊断市场由提供快速血液检测、分散式诊断解决方案和家庭血液监测等服务的营业单位所获得的收益所构成。市场价值还包括服务供应商销售的或包含在其服务产品中的相关产品的价值。照护现场血液学诊断市场还包括可携式血液学分析仪、试剂盒、检测套组、采血采血针和试剂的销售。该市场中的商品价值是“出厂价”，即商品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球照护现场血液诊断：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球照护现场血液学诊断市场：成长率分析
  • 全球照护现场血液学诊断市场表现：规模与成长，2019-2024
  • 全球照护现场血液学诊断市场预测：规模与成长，2024-2029 年，2034 年预测
  • 全球照护现场血液学诊断：总潜在市场（TAM）

第六章 市场细分

  • 全球照护现场血液学诊断市场：依类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全血球计数
  • 血液凝固检验
  • 血红素检测
  • 贫血的诊断
  • 其他类型
  • 全球照护现场血液学诊断市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 耗材
  • 系统
  • 全球照护现场血液学诊断市场（依处方方法、绩效及预测）2019-2024 年、2024-2029 年、2034 年
  • 处方笺产品
  • 非处方药品
  • 全球照护现场血液学诊断市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 诊断中心
  • 医院
  • 血库
  • 输血中心
  • 其他最终用户
  • 全球照护现场血液学诊断市场：依血球计数细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 白血球计数
  • 红血球计数
  • 血小板计数
  • 血球容积比
  • 血红素浓度
  • 平均红血球体积（MCV）
  • 全球照护现场血液学诊断市场：按血液凝固检验类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 凝血酶原时间（PT）
  • 活化部份凝血活酵素时间（aPTT）
  • 国际标准化比率（INR）
  • D-二聚体检测
  • 纤维蛋白原水平
  • 全球照护现场血液学诊断市场：依血红素检测类型细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 总血红素
  • 醣化血红素（HbA1c）
  • 氧合血红素
  • 碳氧血红素
  • 高铁血红素
  • 全球照护现场血液学诊断市场：贫血诊断类型细分、绩效及预测（2019-2024 年、2024-2029 年预测、2034 年预测）
  • 铁研究
  • 维生素 B12 水平
  • 叶酸水平
  • 网状红血球计数
  • 铁蛋白检测
  • 转铁蛋白饱和度
  • 全球照护现场血液学诊断市场：按类型细分、实际结果及预测，2019-2024 年、2024-2029 年、2034 年
  • 血型鑑定与交叉配对试验
  • 红血球沉积速率
  • 疟疾原虫检测
  • 镰状细胞筛检
  • C反应蛋白检测

第七章 区域和国家分析

  • 全球照护现场血液学诊断市场：区域表现及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 全球照护现场血液学诊断市场：国家、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 照护现场血液诊断市场：竞争格局
  • 照护现场血液学诊断市场：公司简介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • Sysmex Corporation
  • HORIBA Ltd.
  • Nova Biomedical Corp.
  • SD Sight Diagnostics Ltd.
  • EKF Diagnostics Holdings plc.
  • Medsource Ozone Biomedicals Pvt. Ltd.
  • BioSystems SA
  • Chengdu Seamaty Technology Co. Ltd.
  • Drucker Diagnostics LLC
  • Diamond Diagnostics Inc.
  • DIAGON Kft.
  • BioMedomics Inc.
  • Norma Instruments Zrt.
  • PixCell Medical Technologies Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年照护现场血液学诊断市场：提供新机会的国家
  • 2029 年照护现场血液学诊断市场：细分市场将带来新机会
  • 2029 年照护现场血液学诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r37859

Point-of-care hematology diagnostics refer to medical tests conducted at or near the site of patient care to quickly evaluate blood-related conditions, such as anemia, infections, or clotting disorders. These tests deliver rapid and accurate hematological results to support timely clinical decisions, particularly in emergency or resource-limited settings. This approach minimizes the reliance on centralized laboratory testing and accelerates diagnosis and treatment.

The primary types of point-of-care hematology diagnostics include complete blood count (CBC), coagulation testing, hemoglobin testing, anemia diagnosis, and others. A CBC measures various blood components, including red blood cells, white blood cells, hemoglobin, hematocrit, and platelets, helping to assess overall health and detect a wide range of disorders. These diagnostics are available as consumables and systems and are offered in both prescription-based and over-the-counter formats, serving end users such as diagnostic centers, hospitals, blood banks, transfusion centers, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The point-of-care hematology diagnostics market research report is one of a series of new reports from The Business Research Company that provides point-of-care hematology diagnostics market statistics, including point-of-care hematology diagnostics industry global market size, regional shares, competitors with a point-of-care hematology diagnostics market share, detailed point-of-care hematology diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care hematology diagnostics industry. This point-of-care hematology diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point of care hematology diagnostics market size has grown strongly in recent years. It will grow from $2.66 billion in 2024 to $2.90 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth during the historic period can be attributed to the increasing prevalence of hematological disorders, the expansion of decentralized healthcare settings, growing focus on early disease detection, rising healthcare expenditures in emerging markets, and the growing adoption of portable diagnostic devices.

The point of care hematology diagnostics market size is expected to see strong growth in the next few years. It will grow to $4.05 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth during the forecast period can be attributed to the increasing adoption of personalized medicine, rising demand for immediate clinical decision-making, growing use of home healthcare diagnostics, higher prevalence of blood-related disorders, and heightened awareness of preventive healthcare. Key trends expected during the forecast period include advanced connectivity features in hematology analyzers, innovations in sample preparation methods, integration of artificial intelligence in diagnostic tools, developments in single-cell analysis, adoption of cloud-based data platforms, and advancements in lab-on-a-chip solutions.

The increasing prevalence of blood disorders is expected to drive significant growth in the point-of-care hematology diagnostics market. Blood disorders are the conditions affecting red blood cells, white blood cells, platelets, or plasma are rising largely due to the growing incidence of chronic diseases, which directly impact blood health and necessitate regular monitoring. Point-of-care hematology diagnostics facilitate timely detection and management of these disorders by providing rapid, accurate results at or near the patient care site, enabling faster clinical decisions and improved disease management. For example, in April 2024, the Perth Blood Institute, an Australia-based non-profit, reported that the number of individuals diagnosed with hemophilia increased to 257,146 in 2022, up from 233,577 in 2021. This trend underscores the critical role of point-of-care hematology diagnostics in addressing the rising incidence of blood disorders.

Key companies in this market are developing advanced solutions, such as cartridge-based AI-powered hematology analyzers, to deliver rapid and precise on-site blood analysis. These compact devices utilize single-use reagent cartridges and artificial intelligence algorithms to perform complete blood counts (CBC) and other analyses directly at the point of care. For instance, in September 2024, Zoetis Inc., a US-based veterinary health company, launched Vetscan OptiCell, a cartridge-based, AI-powered hematology analyzer for veterinary use. This system provides rapid, reference-quality CBC results within minutes, while minimizing maintenance and hands-on time. It features AI-driven image analysis and viscoelastic focusing technology to accurately align cells, classify blood cells, and automatically detect abnormalities, ensuring reliable and efficient diagnostics.

In June 2023, Mars Inc., a US-based pet company, acquired Heska Corporation for an undisclosed amount. This acquisition expands Mars' veterinary diagnostics capabilities and strengthens its position in advanced animal healthcare by leveraging Heska's point-of-care hematology and specialty diagnostic solutions.

Major players in the point of care hematology diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., Medsource Ozone Biomedicals Pvt. Ltd., BioSystems S.A., Chengdu Seamaty Technology Co. Ltd., Drucker Diagnostics LLC, Diamond Diagnostics Inc., DIAGON Kft., BioMedomics Inc., Norma Instruments Zrt., PixCell Medical Technologies Ltd.

North America was the largest region in the point of care hematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in point of care hematology diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the point of care hematology diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point of care hematology diagnostics market consists of revenues earned by entities by providing services such as rapid blood testing, decentralized diagnostic solutions, and home-based blood monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The point of care hematology diagnostics market also includes sales of portable hematology analyzers, cartridges and test kits, lancets, and reagents. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point Of Care Hematology Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on point of care hematology diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point of care hematology diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point of care hematology diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Complete Blood Count; Coagulation Testing; Hemoglobin Testing; Anemia Diagnosis; Other Types
  • 2) By Product: Consumables; Systems
  • 3) By Mode Of Prescription: Prescription Based Product; Over-The-Counter Based Product
  • 4) By End User: Diagnostic Centers; Hospitals; Blood Banks; Transfusion Centers; Other End Users
  • Subsegments:
  • 1) By Complete Blood Count: White Blood Cell Count; Red Blood Cell Count; Platelet Count; Hematocrit; Hemoglobin Concentration; Mean Corpuscular Volume (MCV)
  • 2) By Coagulation Testing: Prothrombin Time (PT); Activated Partial Thromboplastin Time (aPTT); International Normalized Ratio (INR); D-Dimer Test; Fibrinogen Level
  • 3) By Hemoglobin Testing: Total Hemoglobin; Glycated Hemoglobin (HbA1c); Oxyhemoglobin; Carboxyhemoglobin; Methemoglobin
  • 4) By Anemia Diagnosis: Iron Studies; Vitamin B12 Levels; Folate Levels; Reticulocyte Count; Ferritin Test; Transferrin Saturation
  • 5) By Other Types: Blood Typing And Crossmatching; Erythrocyte Sedimentation Rate; Malaria Parasite Detection; Sickle Cell Screening; C-Reactive Protein Testing
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; Sysmex Corporation; HORIBA Ltd.; Nova Biomedical Corp.; S.D. Sight Diagnostics Ltd.; EKF Diagnostics Holdings plc.; Medsource Ozone Biomedicals Pvt. Ltd.; BioSystems S.A.; Chengdu Seamaty Technology Co. Ltd.; Drucker Diagnostics LLC; Diamond Diagnostics Inc.; DIAGON Kft.; BioMedomics Inc.; Norma Instruments Zrt.; PixCell Medical Technologies Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Point Of Care Hematology Diagnostics Market Characteristics

3. Point Of Care Hematology Diagnostics Market Trends And Strategies

4. Point Of Care Hematology Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Point Of Care Hematology Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Point Of Care Hematology Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Point Of Care Hematology Diagnostics Market Growth Rate Analysis
  • 5.4. Global Point Of Care Hematology Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Point Of Care Hematology Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Point Of Care Hematology Diagnostics Total Addressable Market (TAM)

6. Point Of Care Hematology Diagnostics Market Segmentation

  • 6.1. Global Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Complete Blood Count
  • Coagulation Testing
  • Hemoglobin Testing
  • Anemia Diagnosis
  • Other Types
  • 6.2. Global Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consumables
  • Systems
  • 6.3. Global Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prescription Based Product
  • Over-The-Counter Based Product
  • 6.4. Global Point Of Care Hematology Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Centers
  • Hospitals
  • Blood Banks
  • Transfusion Centers
  • Other End Users
  • 6.5. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Complete Blood Count, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • White Blood Cell Count
  • Red Blood Cell Count
  • Platelet Count
  • Hematocrit
  • Hemoglobin Concentration
  • Mean Corpuscular Volume (MCV)
  • 6.6. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Coagulation Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prothrombin Time (PT)
  • Activated Partial Thromboplastin Time (aPTT)
  • International Normalized Ratio (INR)
  • D-Dimer Test
  • Fibrinogen Level
  • 6.7. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Hemoglobin Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Total Hemoglobin
  • Glycated Hemoglobin (HbA1c)
  • Oxyhemoglobin
  • Carboxyhemoglobin
  • Methemoglobin
  • 6.8. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Anemia Diagnosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Iron Studies
  • Vitamin B12 Levels
  • Folate Levels
  • Reticulocyte Count
  • Ferritin Test
  • Transferrin Saturation
  • 6.9. Global Point Of Care Hematology Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Typing And Crossmatching
  • Erythrocyte Sedimentation Rate
  • Malaria Parasite Detection
  • Sickle Cell Screening
  • C-reactive Protein Testing

7. Point Of Care Hematology Diagnostics Market Regional And Country Analysis

  • 7.1. Global Point Of Care Hematology Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Point Of Care Hematology Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Point Of Care Hematology Diagnostics Market

  • 8.1. Asia-Pacific Point Of Care Hematology Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Point Of Care Hematology Diagnostics Market

  • 9.1. China Point Of Care Hematology Diagnostics Market Overview
  • 9.2. China Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Point Of Care Hematology Diagnostics Market

  • 10.1. India Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Point Of Care Hematology Diagnostics Market

  • 11.1. Japan Point Of Care Hematology Diagnostics Market Overview
  • 11.2. Japan Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Point Of Care Hematology Diagnostics Market

  • 12.1. Australia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Point Of Care Hematology Diagnostics Market

  • 13.1. Indonesia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Point Of Care Hematology Diagnostics Market

  • 14.1. South Korea Point Of Care Hematology Diagnostics Market Overview
  • 14.2. South Korea Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Point Of Care Hematology Diagnostics Market

  • 15.1. Western Europe Point Of Care Hematology Diagnostics Market Overview
  • 15.2. Western Europe Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Point Of Care Hematology Diagnostics Market

  • 16.1. UK Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Point Of Care Hematology Diagnostics Market

  • 17.1. Germany Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Point Of Care Hematology Diagnostics Market

  • 18.1. France Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Point Of Care Hematology Diagnostics Market

  • 19.1. Italy Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Point Of Care Hematology Diagnostics Market

  • 20.1. Spain Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Point Of Care Hematology Diagnostics Market

  • 21.1. Eastern Europe Point Of Care Hematology Diagnostics Market Overview
  • 21.2. Eastern Europe Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Point Of Care Hematology Diagnostics Market

  • 22.1. Russia Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Point Of Care Hematology Diagnostics Market

  • 23.1. North America Point Of Care Hematology Diagnostics Market Overview
  • 23.2. North America Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Point Of Care Hematology Diagnostics Market

  • 24.1. USA Point Of Care Hematology Diagnostics Market Overview
  • 24.2. USA Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Point Of Care Hematology Diagnostics Market

  • 25.1. Canada Point Of Care Hematology Diagnostics Market Overview
  • 25.2. Canada Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Point Of Care Hematology Diagnostics Market

  • 26.1. South America Point Of Care Hematology Diagnostics Market Overview
  • 26.2. South America Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Point Of Care Hematology Diagnostics Market

  • 27.1. Brazil Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Point Of Care Hematology Diagnostics Market

  • 28.1. Middle East Point Of Care Hematology Diagnostics Market Overview
  • 28.2. Middle East Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Point Of Care Hematology Diagnostics Market

  • 29.1. Africa Point Of Care Hematology Diagnostics Market Overview
  • 29.2. Africa Point Of Care Hematology Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Point Of Care Hematology Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Point Of Care Hematology Diagnostics Market, Segmentation By Mode Of Prescription, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Point Of Care Hematology Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Point Of Care Hematology Diagnostics Market Competitive Landscape
  • 30.2. Point Of Care Hematology Diagnostics Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Point Of Care Hematology Diagnostics Market Other Major And Innovative Companies

  • 31.1. Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
  • 31.2. Sysmex Corporation
  • 31.3. HORIBA Ltd.
  • 31.4. Nova Biomedical Corp.
  • 31.5. S.D. Sight Diagnostics Ltd.
  • 31.6. EKF Diagnostics Holdings plc.
  • 31.7. Medsource Ozone Biomedicals Pvt. Ltd.
  • 31.8. BioSystems S.A.
  • 31.9. Chengdu Seamaty Technology Co. Ltd.
  • 31.10. Drucker Diagnostics LLC
  • 31.11. Diamond Diagnostics Inc.
  • 31.12. DIAGON Kft.
  • 31.13. BioMedomics Inc.
  • 31.14. Norma Instruments Zrt.
  • 31.15. PixCell Medical Technologies Ltd.

32. Global Point Of Care Hematology Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Point Of Care Hematology Diagnostics Market

34. Recent Developments In The Point Of Care Hematology Diagnostics Market

35. Point Of Care Hematology Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Point Of Care Hematology Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Point Of Care Hematology Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Point Of Care Hematology Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer